Sign in
Join
Click here - to use the wp menu builder
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Create an account
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Search
Type here...
Search
Home
Trending
Analysis
Research Reports
Contact Us
START FREE TRAIL
My account
Get into your account.
Login
Register
Search
Type here...
Search
Home
Trending
Analysis
Research Reports
Contact Us
START FREE TRAIL
My account
Get into your account.
Login
Register
Log In
Profile
Log Out
type here...
Search
Facebook
Instagram
Twitter
Youtube
Log In
Profile
Log Out
type here...
Search
Facebook
Instagram
Twitter
Youtube
Home
About Us
Trending
Analysis
Research Reports
Contact Us
Search
START FREE TRIAL
My account
Get into your account.
Login
Register
Home
About Us
Trending
Analysis
Research Reports
Contact Us
Search
START FREE TRIAL
My account
Get into your account.
Login
Register
Tag:
M&A
M&A
Technology & AI
Healthcare
M&A
Consumer & Retail
Energy
Is The Devon + Coterra $21 Billion Merger About Growth — Or Running Out of Rock?
Energy
Ishan Majumdar
-
February 3, 2026
Devon Energy just announced a $21.4 billion all-stock acquisition of Coterra, positioning itself as one of the largest U.S....
Is Apple Outflanking Meta With This Q.AI Move?
M&A
Ishan Majumdar
-
February 4, 2026
Apple acquired Israeli startup Q.AI for close to $2B, locking down patents around “facial skin micro movements” that enable...
Ascendis Pharma Becomes M&A Target Again—European Suitors In Play?
M&A
Ishan Majumdar
-
January 26, 2026
Ascendis Pharma (NASDAQ:ASND) has suddenly become one of the hottest tickers in biotech circles after its shares surged 7.5%...
PayPal Buys Cymbio—What It Really Means For The Future Of AI Shopping
Finance
Ishan Majumdar
-
January 23, 2026
PayPal is acquiring Cymbio, a Tel Aviv-based platform that helps brands sell across agentic commerce channels. This pushes PayPal...
Boston Scientific Penumbra Acquisition: The $15 Billion Gamble That Could Dominate Neurovascular Markets
Healthcare
Ishan Majumdar
-
January 16, 2026
If you're wondering what Boston Scientific (NYSE:BSX) has been up to lately, buckle up. On January 15, the medtech...
Merck Revolution Medicines Acquisition: The $30 Billion Pipeline Gamble That Could Pay Off
Healthcare
Ishan Majumdar
-
January 10, 2026
Merck (NYSE:MRK) is making headlines again, this time for reportedly circling Revolution Medicines (NASDAQ:RVMD) in what could be one...
Snowflake Acquires Observe AI: The Boldest Move In Cloud Observability Yet!
Technology & AI
Ishan Majumdar
-
January 9, 2026
Snowflake (NYSE:SNOW) just made a quiet but intriguing move that could reshape how enterprises handle observability at scale. On...
Meta Acquires Manus: The Real Reason Behind Zuckerberg’s $2 Billion AI Gamble
Technology & AI
Ishan Majumdar
-
December 30, 2025
Meta Platforms (NASDAQ:META) just made another bold AI move. In a deal reportedly valued north of $2 billion, Meta...
Niagen NR Patent Acquisition Unlocks Massive Pharma Potential—But There’s a Catch!
Healthcare
Ishan Majumdar
-
December 26, 2025
If you blinked, you may have missed one of the more intriguing biotech moves of the year. Niagen Bioscience...
Howmet Buys CAM: The $1.8 Billion Bet That Could Reshape Aerospace
Industrials
Ishan Majumdar
-
December 26, 2025
On December 22, 2025, Howmet Aerospace (NYSE:HWM) announced plans to acquire Consolidated Aerospace Manufacturing (CAM) from Stanley Black &...
BioMarin Amicus Acquisition: A $4.8 Billion Bet on Rare Disease Domination
Healthcare
Ishan Majumdar
-
December 23, 2025
BioMarin Pharmaceutical (NASDAQ:BMRN) just made its boldest move in years—unveiling a $4.8 billion all-cash acquisition of Amicus Therapeutics. The...
WBD Contested Takeover: The $100B Deal the Board May Walk Away From
Media & Entertainment
Ishan Majumdar
-
December 19, 2025
The battle for Warner Bros. Discovery (NASDAQ:WBD) just escalated. Despite Paramount’s $30 all-cash hostile bid, WBD’s board is preparing...
Load more
Is The Devon + Coterra $21 Billion Merger About Growth — Or Running Out of Rock?
Energy
Ishan Majumdar
-
February 3, 2026
Devon Energy just announced a $21.4 billion all-stock acquisition of Coterra, positioning itself as one of the largest U.S....
Is Apple Outflanking Meta With This Q.AI Move?
M&A
Ishan Majumdar
-
January 31, 2026
Apple acquired Israeli startup Q.AI for close to $2B, locking down patents around “facial skin micro movements” that enable...
Ascendis Pharma Becomes M&A Target Again—European Suitors In Play?
M&A
Ishan Majumdar
-
January 26, 2026
Ascendis Pharma (NASDAQ:ASND) has suddenly become one of the hottest tickers in biotech circles after its shares surged 7.5%...
PayPal Buys Cymbio—What It Really Means For The Future Of AI Shopping
Finance
Ishan Majumdar
-
January 23, 2026
PayPal is acquiring Cymbio, a Tel Aviv-based platform that helps brands sell across agentic commerce channels. This pushes PayPal...
Boston Scientific Penumbra Acquisition: The $15 Billion Gamble That Could Dominate Neurovascular Markets
Healthcare
Ishan Majumdar
-
January 16, 2026
If you're wondering what Boston Scientific (NYSE:BSX) has been up to lately, buckle up. On January 15, the medtech...
Merck Revolution Medicines Acquisition: The $30 Billion Pipeline Gamble That Could Pay Off
Healthcare
Ishan Majumdar
-
January 10, 2026
Merck (NYSE:MRK) is making headlines again, this time for reportedly circling Revolution Medicines (NASDAQ:RVMD) in what could be one...
Snowflake Acquires Observe AI: The Boldest Move In Cloud Observability Yet!
Technology & AI
Ishan Majumdar
-
January 9, 2026
Snowflake (NYSE:SNOW) just made a quiet but intriguing move that could reshape how enterprises handle observability at scale. On...
Meta Acquires Manus: The Real Reason Behind Zuckerberg’s $2 Billion AI Gamble
Technology & AI
Ishan Majumdar
-
December 30, 2025
Meta Platforms (NASDAQ:META) just made another bold AI move. In a deal reportedly valued north of $2 billion, Meta...
Niagen NR Patent Acquisition Unlocks Massive Pharma Potential—But There’s a Catch!
Healthcare
Ishan Majumdar
-
December 23, 2025
If you blinked, you may have missed one of the more intriguing biotech moves of the year. Niagen Bioscience...
Howmet Buys CAM: The $1.8 Billion Bet That Could Reshape Aerospace
Industrials
Ishan Majumdar
-
December 23, 2025
On December 22, 2025, Howmet Aerospace (NYSE:HWM) announced plans to acquire Consolidated Aerospace Manufacturing (CAM) from Stanley Black &...
BioMarin Amicus Acquisition: A $4.8 Billion Bet on Rare Disease Domination
Healthcare
Ishan Majumdar
-
December 20, 2025
BioMarin Pharmaceutical (NASDAQ:BMRN) just made its boldest move in years—unveiling a $4.8 billion all-cash acquisition of Amicus Therapeutics. The...
WBD Contested Takeover: The $100B Deal the Board May Walk Away From
Media & Entertainment
Ishan Majumdar
-
December 17, 2025
The battle for Warner Bros. Discovery (NASDAQ:WBD) just escalated. Despite Paramount’s $30 all-cash hostile bid, WBD’s board is preparing...